Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015

Diabetes Care. 2021 Jun;44(6):e137-e138. doi: 10.2337/dci21-0009. Epub 2021 May 20.

¹ Division of Cardiovascular Medicine, Department of Medicine, University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH ian.neeland@uhhospitals.org.
² Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
³ Section of Endocrinology, Yale School of Medicine, Yale University, New Haven, CT.
⁴ Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, Yale University, New Haven, CT.

No abstract available

Publication types